The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice

Abstract Objective To develop and explore a protocol for using colour duplex sonography (CDS) in the routine care of GCA. Methods We tested CDS of temporal arteries and axillary arteries (AXs) on consecutive patients with suspected or established GCA, between July 2014 and September 2016. Results We...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2018-01, Vol.57 (1), p.112-119
Main Authors: Monti, Sara, Floris, Alberto, Ponte, Cristina B, Schmidt, Wolfgang A, Diamantopoulos, Andreas P, Pereira, Claudio, Vaggers, Sophie, Luqmani, Raashid A.
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Arteries
Arteritis
Autoimmune diseases
Axillary Artery - diagnostic imaging
Cardiovascular diseases
Cohort Studies
Female
Giant Cell Arteritis - complications
Giant Cell Arteritis - diagnostic imaging
Giant Cell Arteritis - drug therapy
Glucocorticoids
Glucocorticoids - therapeutic use
Headache - etiology
Humans
Inflammation
Intermittent Claudication - etiology
Jaw
Male
Masticatory Muscles
Medical diagnosis
Middle Aged
Patients
Scalp
Sensitivity and Specificity
Temporal Arteries - diagnostic imaging
Tongue
Ultrasonography
Ultrasonography, Doppler, Color
Ultrasound
Vein & artery diseases
Vision Disorders - etiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective To develop and explore a protocol for using colour duplex sonography (CDS) in the routine care of GCA. Methods We tested CDS of temporal arteries and axillary arteries (AXs) on consecutive patients with suspected or established GCA, between July 2014 and September 2016. Results We assessed 293 patients [age 72 (10), female/male 196/97], of whom 118 had clinically confirmed GCA. Seventy-three percent of patients had already received high-dose glucocorticoids (GCs) for 17 (33) days. Among new referrals with
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/kex341